Antidepressant Augmentation of Antipsychotic Treatment in Schizophrenia: A Narrative Review. [PDF]
Li W +7 more
europepmc +1 more source
Associations between second-generation antipsychotics and metabolic outcomes in patients with schizophrenia and metabolic abnormalities. [PDF]
Liao Z +28 more
europepmc +1 more source
Metabolic and Endocrine ADRs of Atypical Antipsychotics (AAPs) in Paediatric Patients with Autism Spectrum Disorder (ASD): A Review of Prevalence, Risk Factors, and Implications for Clinical Monitoring. [PDF]
Aljead M, Qashta A, Jalal Z, Jones AM.
europepmc +1 more source
Trends in Antipsychotic Drug Use in the United States, 2000-2016. [PDF]
Haddad N +9 more
europepmc +1 more source
Comparison of Antipsychotics in the Treatment of COVID-19-Induced First-Episode Psychosis: A Review of Case Studies. [PDF]
Singh G +6 more
europepmc +1 more source
Efficacy and Safety of Ziprasidone Injection vs Haloperidol Injection for Agitation in Patients with Acute Schizophrenia. [PDF]
Qi S +8 more
europepmc +1 more source
Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis. [PDF]
Olgiati P +7 more
europepmc +1 more source
The Efficacy of Pharmacological Interventions in the Treatment of Major Depressive Disorder and Bipolar Depression With Mixed Features: A Systematic Review. [PDF]
Xiao N +12 more
europepmc +1 more source
Response to: A Commentary on “Antipsychotic-Induced Parkinsonism is Associated with Working Memory Deficits in Schizophrenia-Spectrum Disorders” [PDF]
Andràs Tikàsz, Stéphane Potvin
core +3 more sources
Post-lanosterol inhibition profile based classification of commonly used prescription medications. [PDF]
Tallman KA +4 more
europepmc +1 more source

